CI — Cigna Corporation stock price, charts and financials

QT52Cigna Corporation

Cigna Corporation (NYSE: CI) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
278.17
+2.34+0.85%
CIQT52Cigna Corporation·NYSE
278.17+0.85%
News
Up 0.8% — Cigna Group Executive Neville Everett Sells 617 Shares for $175,000 (fool.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E11.51EPS (ttm)24.16Insider Own0.35%Shs Outstand264.24MPerf Week-1.73%
Market Cap73.50BForward P/E8.31EPS next Y33.48Insider Trans-24.25%Shs Float262.88MPerf Month-0.08%
Enterprise Value99.08BPEG1.04EPS next Q7.46Inst Own88.34%Short Float1.99%Perf Quarter-5.71%
Income6.42BP/S0.26EPS this Y26.24%Inst Trans0.08%Short Ratio3.04Perf Half Y5.99%
Sales282.38BP/B1.71EPS next Y9.78%ROA4.08%Short Interest5.24MPerf YTD1.07%
Book/sh162.39P/C11.67EPS next 5Y11.03%ROE15.24%52W High315.46 -11.82%Perf Year-7.55%
Cash/sh23.83P/FCF8.19EPS past 3/5Y1.17% -0.70%ROIC7.69%52W Low239.51 16.14%Perf 3Y0.54%
Dividend Est.6.24 (2.24%)EV/EBITDA8.42Sales past 3/5Y15.06% 11.38%Gross Margin11.66%Volatility2.06% 1.89%Perf 5Y31.43%
Dividend TTM6.19 (2.23%)EV/Sales0.35EPS Y/Y TTM99.34%Oper. Margin3.46%ATR (14)6.62Perf 10Y116.49%
Dividend Ex-DateSep 08, 2026Quick Ratio0.74Sales Y/Y TTM14.27%Profit Margin2.27%RSI (14)47.55Recom2.28
Dividend Gr. 3/5Y10.47% 172.77%Current Ratio0.85EPS Q/Q8.06%SMA20-0.35%Beta0.29Target Price338.33
Payout25.31%Debt/Eq0.75Sales Q/Q6.60%SMA50-1.81%Rel Volume0.93Prev Close275.83
Employees66,685LT Debt/Eq0.74EarningsOct 29SMA200-0.52%Avg Volume1.66MPrice278.17
IPO DateMar 31, 1982Option/ShortYes / YesEPS/Sales Surpr.2.42% 2.17%Net Debt/EBITDA2.17Volume1,542,767Change0.85%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-04-26DowngradeJefferiesBuyHold$330$307
Aug-03-26DowngradeRaymond JamesStrong BuyOutperform$340$320
Jul-31-26ReiteratedRobert W. Baird$337$362
Jul-31-26ReiteratedWells FargoEqual Weight$300$307
Jul-31-26ReiteratedGuggenheimBuy$318$361
Jun-16-26ReiteratedWolfe Research$294$315
Jun-08-26ReiteratedMizuhoOutperform$330$340
May-26-26DowngradeBarclaysOverweightEqual Weight$310$304
May-22-26ReiteratedUBSBuy$375$400
May-20-26ReiteratedMorgan StanleyOverweight$355$361
Latest News· Times ET
Sep-09-26
Sep-08-26
Sep-03-26
Aug-31-26
Aug-29-26
Aug-28-26
Aug-27-26
Aug-26-26
Aug-25-26
Aug-24-26
Company

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

Ownership
Total institutional ownership88.34%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue282,382274,952247,121
Cost of Goods Sold Incl. D&A249,453248,966221,157
Gross Profit32,92925,98625,964
Selling, General and Administrative Excl. Other13,96014,00014,569
Research and Development
000
Other Operating Expense9,2092,8571,978
Operating Income9,7609,1299,417
Interest Expense1,3951,3811,435
Unusual Expense
Non-Operating Income (Expense)86-155-2,713
Net Income Before Taxes8,4517,5935,269
Income Taxes1,5081,3451,491
Consolidated Net Income6,4165,9573,434
Net Income From Continuing Operations6,9436,2483,778
Net Income6,4165,9573,434
EPS (Recurring)24.2522.3012.25
EPS (Basic, Before Extraordinaries)24.2522.3012.25
EPS (Diluted)24.1622.1712.12
EBITDA11,77311,60711,446
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio11.5112.4122.78
Price To Sales Ratio0.260.270.31
Gross Margin11.669.4510.51
Operating Margin3.463.323.81
Net Margin2.272.171.39
Shares Outstanding264266280
Market Capitalization73,43773,21177,319
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$347.89$318.64$289.40$260.16$230.91 Close Price0.00M14.78M29.56M44.34M59.11MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Neville EverettSee RemarksSep 03 '26Sale284.05617175,2595,053Sep 08
Jones Nicole SSee RemarksAug 18 '26Sale279.612,677748,51625,880Aug 20
Jones Nicole SSee RemarksAug 05 '26Option Exercise192.021,301249,81828,557Aug 06
Jones Nicole SSee RemarksAug 04 '26Sale276.2719,4365,369,58427,256Aug 06
Jones Nicole SSee RemarksAug 04 '26Option Exercise192.0214,0452,696,92146,692Aug 06
Kates Jamie GChief Accounting OfficerJun 12 '26Option Exercise152.89899137,4523,267Jun 16
Kates Jamie GChief Accounting OfficerJun 12 '26Sale298.61899268,4522,368Jun 16
Cordani DavidChairman & CEOMay 13 '26Option Exercise165.5423,4293,878,40657,766May 14
Cordani DavidChairman & CEOMay 12 '26Sale292.82201,87859,114,18734,337May 14
Cordani DavidChairman & CEOMay 12 '26Option Exercise170.94189,11432,326,815236,215May 14
Jones Nicole SSee RemarksMar 02 '26Sale288.912,307666,51532,647Mar 03
Neville EverettSee RemarksMar 02 '26Sale288.911,719496,6365,670Mar 03
Cordani DavidChairman & CEONov 03 '25Buy241.884,134999,916157,935Nov 03
Evanko Brian CSee RemarksOct 06 '25Option Exercise139.22901125,43752,083Oct 07
Evanko Brian CSee RemarksOct 03 '25Sale300.005,3681,610,40051,182Oct 07
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.